Price & volume screen · refreshed after the Nov 11, 2026 close
Six-month momentum leaders: Healthcare
Large companies with the strongest six-month price performance. Ranks companies worth at least $1B by their six-month split-adjusted return.
| # | Company | Price | 1M | 6M | From high | Mkt cap |
|---|---|---|---|---|---|---|
| 251 | MLTXMoonLake ImmunotherapeuticsHealthcare | $13.75 | +32.1% | −25.3% | −38.0% | $1.17B |
| 252 | XENEXenon PharmaceuticalsHealthcare | $41.72 | +21.2% | −25.3% | −41.2% | $4.10B |
| 253 | OCULOcular TherapeutixHealthcare | $6.63 | −8.5% | −28.3% | −58.9% | $1.46B |
| 254 | AHCOAdaptHealthHealthcare | $7.75 | +22.4% | −28.4% | −42.1% | $1.06B |
| 255 | BKDBrookdale Senior LivingHealthcare | $9.11 | −10.0% | −29.2% | −45.7% | $2.18B |
| 256 | RAPPRapport TherapeuticsHealthcare | $26.57 | −8.3% | −30.2% | −49.4% | $1.58B |
| 257 | JBIOJade BiosciencesHealthcare | $16.95 | +26.3% | −32.4% | −36.9% | $1.08B |
| 258 | NVCRNovoCure LimitedHealthcare | $11.92 | −16.6% | −34.1% | −40.4% | $1.39B |
| 259 | VCYTVeracyteHealthcare | $25.05 | −41.9% | −34.5% | −58.6% | $2.02B |
| 260 | AXSMAxsome TherapeuticsHealthcare | $148.65 | −4.9% | −36.8% | −41.7% | $7.82B |
| 261 | ARWRArrowhead ResearchHealthcare | $49.07 | −15.6% | −37.0% | −45.2% | $6.93B |
| 262 | RAREUltragenyx PharmaceuticalHealthcare | $16.67 | +11.7% | −37.0% | −54.4% | $1.70B |
| 263 | COHRCoherentHealthcare | $240.68 | −17.0% | −40.4% | −43.6% | $47.40B |
| 264 | MLYSMineralys TherapeuticsHealthcare | $15.86 | −24.5% | −41.0% | −66.5% | $1.40B |
| 265 | TYRATyra BiosciencesHealthcare | $21.02 | +13.2% | −41.9% | −46.9% | $1.44B |
| 266 | SUPNSupernusHealthcare | $29.40 | −30.0% | −42.8% | −47.8% | $1.71B |
| 267 | ALNYAlnylam PharmaceuticalsHealthcare | $157.97 | −29.4% | −45.8% | −66.6% | $21.16B |
| 268 | NAMSNewAmsterdam Pharma Company N.VHealthcare | $20.29 | +0.5% | −46.3% | −51.0% | $2.43B |
| 269 | CELCCelcuityHealthcare | $65.74 | +4.0% | −47.2% | −54.7% | $3.22B |
| 270 | NKTRNektar TherapeuticsHealthcare | $38.53 | +1.6% | −49.3% | −61.6% | $1.32B |
| 271 | IONSIonis PharmaceuticalsHealthcare | $29.07 | −31.4% | −62.5% | −66.4% | $4.84B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.